Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.
Gossner
L
L
Department of Medicine, University of Erlangen-Nuremberg, Germany.
Wittke
H
H
Warzecha
A
A
Sroka
R
R
Ernst
H
H
Meier
M
M
Ell
C
C
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002460:Cell Line; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy* / Q000473:pathology; D017324:Hematoporphyrin Derivative; D006415:Hematoporphyrins / Q000627:therapeutic use*; D008027:Light; D051379:Mice; D008809:Mice, Inbred C3H; D009336:Necrosis; D010778:Photochemotherapy; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D012513:Sarcoma, Experimental / Q000188:drug therapy* / Q000473:pathology; D014700:Verapamil / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D006415:Hematoporphyrins; D011838:Radiation-Sensitizing Agents; D017324:Hematoporphyrin Derivative; D014700:Verapamil